Filtyp
The Global Diabetes Alliance Background The Global Diabetes Alliance (GDA) is a not-for-profit international alliance, established in 2007 and steered by a multinational collaborative panel of leading scientists in the field of diabetes. The GDA is forming a growing ‘virtual diabetes research community’, that is responding to the “tsunami” of diabetes, which threatens the well-being of millions of
https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/gda - 2025-07-17
DIAbetes type 1 Prediction, Early Pathogenesis and Prevention The collaborative project DIAPREPP specifically addresses the call FP7 Cooperation Work Programme: Health-2007-2.4.3-1 Early processes in the pathogenesis of type 1 diabetes and strategies for early prevention. The coordinator is Ezio Bonfacio, Dresden, Germany. The earliest currently identifiable process in the pathogenesis of type 1
https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/diaprepp - 2025-07-17
Diabetes Prevention - Immune Tolerance DiAPREV-IT is the first prevention trial with DiamydTM, the alum formulated GAD65 “vaccine”, in children with positive islet cell autoantibodies but not yet diabetes. In the investigator initiated, placebo controlled, and double blind study, children from 4 years of age with positive GAD65-antibodies and at least one more positive islet cell autoantibody will
https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/diaprev-it - 2025-07-17
Retinopathy After Diabetes Onset Diabetes retinopathy (DR) refers to any of the vascular changes in the retina. These are observed clinically as microaneurysms, dot and blot hemorrhages, edema, hard and soft exudates, neovascularization and newly formed fibrovascular tissue. The major sight-threatening manifestations of DR, macular edema and proliferative diabetes retinopathy, PDR, are the end res
https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/read - 2025-07-17
Diabetes and cardiovascular risk factors DOHK is the acronym for the Swedish Diabetes och Hjärta-Kärl. Patients diagnosed with diabetes have an increased risk to develop cardiovascular complications such as acute myocardial infarction (AMI) and stroke. Up to today, about 30 different genes have been identified as predisposing for type 1 diabetes. Furthermore, about 60 different genes have shown
https://www.ludc.lu.se/research/diabetes-and-celiac-disease/research-projects/dohk - 2025-07-17
Consultant
https://www.ludc.lu.se/innovation/innovation-board/lars-hedbys - 2025-07-17
Member of the Hjelt Foundation, Geneva
https://www.ludc.lu.se/innovation/innovation-board/paola-hjelt - 2025-07-17
23 October 2025 09:00 to 17:00 | Conference SciLifeLab Lund Day 2025! Welcome to SciLifeLab Lund Day 2025! Join us for a dynamic day that brings together researchers, technology platforms, and strategic research initiatives to spotlight the powerful synergies driving life science forward in southern Sweden. This year’s program will feature:A showcase of SciLifeLab’s cutting-edge technologies and n
13 November 2025 15:00 to 19:00 | Lecture/talk Världsdiabetesdagen Skåne som i år arrangeras torsdagen den 13 november sätter fokus på hälsa och välbefinnande vid diabetes. Foto: Kennet Ruona Vilken betydelse har kost, träning och diabetesteknik för den som lever med diabetes? Världsdiabetesdagen Skåne som arrangeras torsdagen den 13 november sätter fokus på hälsa och välbefinnande vid diabetes. A
https://www.ludc.lu.se/calendar/varldsdiabetsdagen-skane-2025-halsa-och-valbefinnande-vid-diabetes - 2025-07-17
19 September 2025 14:00 to 15:00 | Seminar Join the EXODIAB webinars for lectures in diabetes research at Lund University and Uppsala University. The webinars are arranged by EXODIAB (Excellence of Diabetes Research in Sweden), a joint strategic research initiative in the diabetes area by Lund University and Uppsala University. These webinars are aimed at diabetes researchers within EXODIAB and di
https://www.ludc.lu.se/calendar/exodiab-webinar-3 - 2025-07-17
17 October 2025 14:00 to 15:00 | Seminar Join the EXODIAB webinars for lectures in diabetes research at Lund University and Uppsala University. The webinars are arranged by EXODIAB (Excellence of Diabetes Research in Sweden), a joint strategic research initiative in the diabetes area by Lund University and Uppsala University. These webinars are aimed at diabetes researchers within EXODIAB and diab
https://www.ludc.lu.se/calendar/exodiab-webinar-4 - 2025-07-17
21 November 2025 14:00 to 15:00 | Seminar Join the EXODIAB webinars for lectures in diabetes research at Lund University and Uppsala University. The webinars are arranged by EXODIAB (Excellence of Diabetes Research in Sweden), a joint strategic research initiative in the diabetes area by Lund University and Uppsala University. These webinars are aimed at diabetes researchers within EXODIAB and dia
https://www.ludc.lu.se/calendar/exodiab-webinar-5 - 2025-07-17
https://www.ludc.lu.se/about-us-old - 2025-07-17
Lund University Diabetes Centre, LUDC, is a consortium of research groups at Lund University dedicated to unravelling the pathogenesis and treatment of diabetes mellitus. LUDC started July 1st 2006 when selected for funding by the Swedish Research Council (Vetenskapsrådet) in fierce national competition, as a part of the call for applications for Linneaus grants. We are active in several different
https://www.ludc.lu.se/about-us/welcome-lund-university-diabetes-centre - 2025-07-17
